This economic evaluation study assesses the clinical benefit of novel drugs approved in 2018 and 2019 and examines whether drugs approved with special regulatory designations appear to provide meaningful therapeutic value.
No takes yet. Share an insight, caveat, or question.
Vokinger et al. (2022) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: